Cure My Disease

Don't miss your cure!

 Log in / Sign up

Experimental vaccine aims to train immune system against Hard-to-Treat colorectal cancer

NCT ID NCT07510308

Recruiting now Disease control Sponsor: West China Hospital Source: ClinicalTrials.gov ↗

First seen Apr 09, 2026 · Last updated May 15, 2026 · Updated 9 times

Summary

This early-stage trial tests a personalized vaccine made from a patient's own tumor cells, modified to boost the immune system's attack on advanced colorectal cancer that hasn't responded to standard treatments. About 9 adults will receive several vaccine injections over months, with close monitoring for side effects and signs of tumor shrinkage. The main goal is to see if the vaccine is safe and tolerable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PMMR/MSS ADVANCED COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, China

Conditions

Explore the condition pages connected to this study.

PMMR/MSS ADVANCED COLORECTAL CANCER